The patent on weight loss injection semaglutide is due to expire in 2031, which will let other companies make cut-price ...

Something hiding in everyday foods like rice, wheat, apples, and coffee could potentially help protect your heart from ...

Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...

Discover how semaglutide reduces heart attack and stroke risk by 20% in overweight individuals, with benefits appearing ...

A game-changing medication known for diabetes and weight loss might also hold the key to improving liver health for millions of Americans.

Limited effectiveness, weight regain, and high prevalence of adverse events are the three key limitations of semaglutide ...

Researchers have found in a new study that semaglutide could provide cardiovascular benefits to high-risk patients even ...

Denmark’s Novo Nordisk has presented data at the European Congress of Obesity (ECO) showing that Wegovy (semaglutide ...

Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or ...

New data suggests the weight-loss drug Wegovy may significantly reduce the risk of heart disease even before users experience ...

Novo Nordisk’s Wegovy (semaglutide injection) 2.4mg has demonstrated early protection against heart disease, according to new ...

I recently read this morning that the shingles vaccine, Shingrix, “may have a protective effect against dementia.” It goes on ...